FR2867684B1 - Gel creme contenant de l'ivermectine - Google Patents

Gel creme contenant de l'ivermectine

Info

Publication number
FR2867684B1
FR2867684B1 FR0402798A FR0402798A FR2867684B1 FR 2867684 B1 FR2867684 B1 FR 2867684B1 FR 0402798 A FR0402798 A FR 0402798A FR 0402798 A FR0402798 A FR 0402798A FR 2867684 B1 FR2867684 B1 FR 2867684B1
Authority
FR
France
Prior art keywords
gel containing
cream gel
containing ivermectin
ivermectin
cream
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0402798A
Other languages
English (en)
Other versions
FR2867684A1 (fr
Inventor
Fanny Astruc
Sandrine Orsoni
Laurent Fredon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma SA
Original Assignee
Galderma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma SA filed Critical Galderma SA
Priority to FR0402798A priority Critical patent/FR2867684B1/fr
Priority to ARP050101014A priority patent/AR049009A1/es
Priority to PCT/EP2005/003718 priority patent/WO2005089806A1/fr
Priority to AT05732385T priority patent/ATE465758T1/de
Priority to BRPI0508167-0A priority patent/BRPI0508167A/pt
Priority to JP2007503311A priority patent/JP5248853B2/ja
Priority to KR1020067016847A priority patent/KR101278806B1/ko
Priority to AU2005224038A priority patent/AU2005224038B2/en
Priority to RU2006136805/15A priority patent/RU2389494C2/ru
Priority to DE602005020912T priority patent/DE602005020912D1/de
Priority to CA2558254A priority patent/CA2558254C/fr
Priority to ES05732385T priority patent/ES2345664T3/es
Priority to EP05732385A priority patent/EP1729811B1/fr
Priority to CN2005800084561A priority patent/CN1933856B/zh
Publication of FR2867684A1 publication Critical patent/FR2867684A1/fr
Application granted granted Critical
Publication of FR2867684B1 publication Critical patent/FR2867684B1/fr
Priority to ZA200606667A priority patent/ZA200606667B/en
Priority to US11/522,312 priority patent/US8858967B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
FR0402798A 2004-03-18 2004-03-18 Gel creme contenant de l'ivermectine Expired - Fee Related FR2867684B1 (fr)

Priority Applications (16)

Application Number Priority Date Filing Date Title
FR0402798A FR2867684B1 (fr) 2004-03-18 2004-03-18 Gel creme contenant de l'ivermectine
ARP050101014A AR049009A1 (es) 2004-03-18 2005-03-16 Gel - crema que contiene ivermectina
ES05732385T ES2345664T3 (es) 2004-03-18 2005-03-17 Gel-crema que contiene avermectina.
BRPI0508167-0A BRPI0508167A (pt) 2004-03-18 2005-03-17 composição farmacêutica, seu processo de preparação e seu uso
JP2007503311A JP5248853B2 (ja) 2004-03-18 2005-03-17 アイバメクチンを含むクリーム−ゲル
KR1020067016847A KR101278806B1 (ko) 2004-03-18 2005-03-17 이버멕틴 함유 크림-젤
AU2005224038A AU2005224038B2 (en) 2004-03-18 2005-03-17 Cream-gel containing ivermectin
RU2006136805/15A RU2389494C2 (ru) 2004-03-18 2005-03-17 Крем-гель, содержащий ивермектин
PCT/EP2005/003718 WO2005089806A1 (fr) 2004-03-18 2005-03-17 Gel-creme contenant de l'invermectine
CA2558254A CA2558254C (fr) 2004-03-18 2005-03-17 Gel-creme contenant de l'invermectine
AT05732385T ATE465758T1 (de) 2004-03-18 2005-03-17 Ivermectin enthaltende creme
EP05732385A EP1729811B1 (fr) 2004-03-18 2005-03-17 Gel-creme contenant de l'ivermectine
CN2005800084561A CN1933856B (zh) 2004-03-18 2005-03-17 含有伊维菌素的乳膏-凝胶
DE602005020912T DE602005020912D1 (de) 2004-03-18 2005-03-17 Ivermectin enthaltende creme
ZA200606667A ZA200606667B (en) 2004-03-18 2006-08-11 Cream-gel containing ivermectin
US11/522,312 US8858967B2 (en) 2004-03-18 2006-09-18 Dermatological cream-gels containing avermectin compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0402798A FR2867684B1 (fr) 2004-03-18 2004-03-18 Gel creme contenant de l'ivermectine

Publications (2)

Publication Number Publication Date
FR2867684A1 FR2867684A1 (fr) 2005-09-23
FR2867684B1 true FR2867684B1 (fr) 2006-05-05

Family

ID=34896615

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0402798A Expired - Fee Related FR2867684B1 (fr) 2004-03-18 2004-03-18 Gel creme contenant de l'ivermectine

Country Status (14)

Country Link
EP (1) EP1729811B1 (fr)
JP (1) JP5248853B2 (fr)
KR (1) KR101278806B1 (fr)
CN (1) CN1933856B (fr)
AR (1) AR049009A1 (fr)
AT (1) ATE465758T1 (fr)
AU (1) AU2005224038B2 (fr)
BR (1) BRPI0508167A (fr)
CA (1) CA2558254C (fr)
ES (1) ES2345664T3 (fr)
FR (1) FR2867684B1 (fr)
RU (1) RU2389494C2 (fr)
WO (1) WO2005089806A1 (fr)
ZA (1) ZA200606667B (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2350333C3 (ru) 2003-04-24 2018-08-24 Галдерма С.А. Применение ивермектина для лечения дерматологических расстройств
FR2854074B1 (fr) 2003-04-24 2007-11-23 Galderma Res & Dev Utilisation de l'ivermectine pour le traitement de desordres dermatologiques
JP2009510049A (ja) * 2005-09-30 2009-03-12 ガルデルマ・ソシエテ・アノニム 眼科症状の治療における、アベルメクチンファミリーまたはミルベマイシンファミリーの少なくとも１つの化合物の使用
FR2894823B1 (fr) 2005-12-20 2008-02-29 Galderma Sa Composition de type emulsion inverse comprenant de l'ivermectine, et ses utilisations en cosmetique et en dermatologie
FR2900052B1 (fr) * 2006-04-19 2011-02-18 Galderma Sa Composition comprenant au moins une phase aqueuse et au moins une phase grasse comprenant de l'ivermectine
FR2903002B1 (fr) * 2006-07-03 2012-08-17 Oreal Composition associant un derive c-glycoside et un polymere emulsionnant
FR2902999B1 (fr) 2006-07-03 2012-09-28 Oreal Utilisation de derives c-glycoside a titre d'actif prodesquamant
FR2906467B1 (fr) * 2006-09-28 2012-11-09 Galderma Sa Utilisation de composes de la famille des milbemycines pour le traitement de desordres dermatologiques chez l'homme
FR2906465B1 (fr) * 2006-09-28 2008-11-28 Galderma Sa Utilisation de composes de la famille des avermectines pour le traitement de desordres dermatologiques chez l'homme
FR2906468B1 (fr) * 2006-09-28 2012-09-21 Galderma Sa Utilisation de composes de la famille des avermectines pour le traitement de desordres dermatologiques
FR2906469B1 (fr) * 2006-09-28 2008-11-28 Galderma Sa Utilisation de composes de la famille des avermectines pour le traitement de desordres dermatologiques chez l'homme
FR2906466B1 (fr) * 2006-09-28 2008-11-28 Galderma Sa Utilisation de composes de la famille des milbemycines pour le traitement de desordres dermatologiques chez l'homme
MX2009006393A (es) * 2006-12-15 2009-09-02 Colgate Palmolive Co Composición detergente líquida.
US8901163B2 (en) * 2007-01-03 2014-12-02 Galderma S.A. Method of treating hyperesthesia, paresthesia, dolor, and pruritus caused by insect stings or noxious weeds or plants using avermectin compound
FR2937972B1 (fr) 2008-11-04 2013-03-29 Galderma Res & Dev Derives d'oxoazetidine, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique
TW201041508A (en) * 2009-04-30 2010-12-01 Dow Agrosciences Llc Pesticide compositions exhibiting enhanced activity
CN103356687B (zh) * 2012-10-19 2016-06-01 厦门大学 一种伊维菌素及其衍生物的用途
RU2530644C2 (ru) * 2012-11-01 2014-10-10 Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") Противоугревая фармацевтическая композиция и способ ее получения
FR3002444B1 (fr) * 2013-02-25 2015-03-13 Oreal Composition cosmetique de type gel
FR3002448B1 (fr) * 2013-02-25 2015-04-03 Oreal Composition cosmetique de type gel
US9782425B2 (en) 2013-07-08 2017-10-10 Galderma S.A. Treatment of papulopustular rosacea with ivermectin
US9233117B2 (en) 2013-07-08 2016-01-12 Galderma S. A. Treatment of inflammatory lesions of rosacea with ivermectin
EP3074021B1 (fr) * 2013-11-29 2021-05-12 Galderma SA Composé de la famille des avermectines ou de la famille des milbémycines pour le traitement et/ou la prévention de la dermatite atopique
CN106029055B (zh) 2014-01-20 2020-08-14 勃林格殷格翰动物保健美国公司 局部递送配制剂
EP3362045B1 (fr) 2015-10-13 2019-10-09 Galderma S.A. Procédé de préparation d'une composition ayant une concentration élevée des avermectins
EP3362097B1 (fr) 2015-10-13 2021-07-14 Galderma S.A. Procédé de préparation d'une émulsion stable comprenant une ou plusieurs avermectines
EP4062907A1 (fr) 2021-03-23 2022-09-28 Substipharm Formulation par voie orale d'ivermectine et utilisations
CN116421560A (zh) * 2023-05-26 2023-07-14 山东中牧兽药有限公司 一种阿苯达唑伊维菌素的微乳剂及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR880005918A (ko) * 1986-11-10 1988-07-21 원본미기재 안정하며 빨리 분해되는 국소피부조성물
US5952372A (en) * 1998-09-17 1999-09-14 Mcdaniel; William Robert Method for treating rosacea using oral or topical ivermectin
IL144561A0 (en) * 1999-01-25 2002-05-23 Optime Therapeutics Inc Liposome compositions and methods for treating pests utilizing the same
CN1237337A (zh) * 1999-05-26 1999-12-08 解俊峰 阿维菌素、伊维菌素微乳剂
US6133310A (en) * 1999-08-26 2000-10-17 Parks; L. Dean Method of treatment of rosacea
US6399651B1 (en) * 2000-06-29 2002-06-04 L. Dean Parks Method of treating dermatoses using avermectin compound
US6319945B1 (en) * 2000-06-29 2001-11-20 L. Dean Parks Method of treatment of seborrheic dermatitis
US6399652B1 (en) * 2000-06-29 2002-06-04 L. Dean Parks Method of treating acne vulgaris using avermectin compound
AU2003215011A1 (en) * 2002-02-08 2003-09-02 Mcneil-Ppc, Inc. Topical ivermectin composition
RU2350333C3 (ru) * 2003-04-24 2018-08-24 Галдерма С.А. Применение ивермектина для лечения дерматологических расстройств
FR2854074B1 (fr) * 2003-04-24 2007-11-23 Galderma Res & Dev Utilisation de l'ivermectine pour le traitement de desordres dermatologiques

Also Published As

Publication number Publication date
AR049009A1 (es) 2006-06-21
ES2345664T3 (es) 2010-09-29
ZA200606667B (en) 2007-10-31
RU2006136805A (ru) 2008-04-27
KR101278806B1 (ko) 2013-06-25
AU2005224038B2 (en) 2011-06-23
AU2005224038A1 (en) 2005-09-29
WO2005089806A1 (fr) 2005-09-29
RU2389494C2 (ru) 2010-05-20
EP1729811B1 (fr) 2010-04-28
JP5248853B2 (ja) 2013-07-31
CA2558254A1 (fr) 2005-09-29
CA2558254C (fr) 2013-01-15
JP2007529465A (ja) 2007-10-25
EP1729811A1 (fr) 2006-12-13
KR20070001148A (ko) 2007-01-03
CN1933856B (zh) 2010-12-08
BRPI0508167A (pt) 2007-08-07
FR2867684A1 (fr) 2005-09-23
ATE465758T1 (de) 2010-05-15
CN1933856A (zh) 2007-03-21

Similar Documents

Publication Publication Date Title
FR2867684B1 (fr) Gel creme contenant de l'ivermectine
DE602005020912D1 (de) Ivermectin enthaltende creme
FR16C1012I2 (fr) Utilisation therapeutique d'anticorps anti-cs1
LTC1620113I2 (lt) Ivermektino topinė kompozicija, skirta dermatologinių susirgimų gydymui
HK1095739A1 (en) Skin care composition
DK1506781T3 (da) Vaginalplejesammensætning
FR2829693B1 (fr) Creme cosmetique moussante
DE60304102D1 (de) Hautreinigungszusammensetzung
DK1313769T3 (da) Antistoffer mod humant IL-1beta
FR2852392B1 (fr) Composition de fixation tissulaire
DE60223576D1 (de) Hautbehandlungszusammensetzung
DK1308163T3 (da) Endoparasiticid gelsammensætning
DE502004005673D1 (de) Medizinisches Instrument
EP1651760A4 (fr) Proteines sanguines humaines exprimees dans des graines de monocotyledone
DE602004000627D1 (de) Hautreinigungsmittel
FR2845267B1 (fr) Kit cutane de diagnostic de l'atopie
ITMI20030778A1 (it) Procedimento per la preparazione enzimatica dell'aroma di vaniglia.
IS7902A (is) Blettaeyðandi samsetning fyrir húðumhirðu
DE112004002142D2 (de) Hautcreme
MXPA03002695A (es) Composicion para el cuidado personal que comprende gel hidrofobo.
FR2842420B1 (fr) Composition cosmetique comprenant de l'ubiquitine
UA8303S (uk) Сумочка жіноча
UA8302S (uk) Сумочка жіноча
FR2857021B1 (fr) Liqueurs d'olives
ES1054827Y (es) "purificador de gasoil"

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 12

ST Notification of lapse

Effective date: 20161130